Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and NeurotologyHumansBevacizumabAdultMaleFemale
The Association Between Age and Outcomes of Bevacizumab Treatment in NF2-Related Schwannomatosis.
Maya G Hatley, Kaleb H Yohay, J Thomas Roland, Devorah Segal
Published: 202610.1097/MAO.0000000000004759
Abstract
OBJECTIVE: NF2-related schwannomatosis (NF2-SWN) is an autosomal dominant genetic disorder characterized by the development of schwannomas, meningiomas, and spinal ependymomas. Treatment with bevacizumab, a monoclonal antibody against VEGF, has been…
Preview only. Read the full abstract at the source